Quantcast
Home > Quotes > CAPR

Capricor Therapeutics, Inc. Common Stock (CAPR) Quote & Summary Data

CAPR 
$0.92
*  
0.04
4.55%
Get CAPR Alerts
*Delayed - data as of Nov. 16, 2018  -  Find a broker to begin trading CAPR now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
6.3
Today's High / Low
$ 0.95 / $ 0.8801
Share Volume
21,725
50 Day Avg. Daily Volume
134,292
Previous Close
$ 0.88
52 Week High / Low
$ 2.48 / $ 0.6577
Market Cap
28,288,962
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
1.16

Intraday Chart

Shares Traded

Share Volume:
21,725
50 Day Avg. Daily Volume:
134,292

Trading Range

The current last sale of $0.92 is 39.88% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 0.95 $ 2.48
 Low: $ 0.8801 $ 0.6577

Company Description (as filed with the SEC)

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy, or DMD, and other medical conditions. We were originally incorporated in Delaware in August 2005 under the name Nile Pharmaceuticals, Inc. and we changed our name to Nile Therapeutics, Inc., or Nile, in January 2007.  ... More ...  


Risk Grade

Where does CAPR fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 0.8897
Open Date:
Nov. 16, 2018
Close Price:
$ 0.88
Close Date:
Nov. 16, 2018

Consensus Recommendation

Analyst Info



Another Bailout?? Why is the SEC boosting big banks and HFT's bottom lines?
x